Patent · US Expired

Peptides derived from a retrovirus of the HIV group and their use

US6869608B2 · kind B2 · utility

1Cited by

8References

12Claims

0Family size

Assignee

Dade Behring Marburg GmbH · DE

Inventors

Stefan Brust · Marburg, DE
Stefan Knapp · Marburg, DE
Manfred Gerken · Marburg, DE
Lutz G. Guertler · Munich, DE

Key dates

Filing date	Dec 4, 2001
Grant date	Mar 22, 2005
Priority date	—
Expiry date	Sep 17, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/16134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Immunologically active peptides which are derived from a novel immunodeficiency virus which has the designation MVP5180/91 are described. A diagnostic containing such a peptide and methods of detecting an antibody against a retrovirus that causes immune deficiency using such diagnostic composition are also described. A kit containing the immunologically active peptides is also described. An immunogen and method of immunizing a mammal against HIV infection using the immunologically active peptides is described. DNA encoding the peptides and methods of detecting nucleic acids encoding HIV viruses are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.